DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Pfizer (NYSE: PFE)

company name or ticker
Company Photos
(Click to zoom)

Bristol-Myers Squibb and Pfizer Inc.'s Bet on This Small Biotech Stock Could Pay Off

Sales of Bristol-Myers Squibb and Pfizer's Eliquis could grow if Portola Pharmaceuticals' andexanet alfa eventually gets FDA approval.

5 Drug Classes Where Prescription Spending Could Grow the Quickest

Prescription drug spending is about to rocket higher and these five drug classes are the reason why.

Best Idea For 2014: Sanofi Rights Post-FDA Approval

Intra-Cellular Commences Phase III Schizophrenia Study - Analyst Blog

CNBC'S Catherine Boyle Doesn't Think A Pfizer/AstraZeneca Deal Will Happen Soon

Why A Merck Clinical Trial May Help Amgen And Regeneron Shares To Set Higher Highs

Dow Movers: CVX, PFE

3 Stocks Reiterated As A Buy: PFE, MU, YHOO

5 Things Pfizer, Inc.'s Management Wants You to Know

Pfizer's third-quarter earnings report looked rather tame unless you dug into its quarterly conference call. Here are the five key things Pfizer's management wants you to know about where the company is headed next.

The 4 Stocks That Lifted the DJIA